VELOXIS
LIVE

Serial Number

97753205

Owner

Veloxis Pharmaceuticals, Inc.

Attorney

Julia Anne Matheson

Filing Date

Jan 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VELOXIS Trademark

Serial Number: 97753205 • Registration: 8055155

VELOXIS is a trademark filed by Veloxis Pharmaceuticals, Inc. on January 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Veloxis Pharmaceuticals, Inc. (12 trademarks)

2000 Regency Parkway,

Entity Type: 99

Trademark Details

Filing Date

January 13, 2023

Registration Date

December 9, 2025

Published for Opposition

October 21, 2025

Goods & Services

Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplant patients; pharmaceutical preparations and drug delivery systems, pharmaceutical modified release systems, and pharmaceutical controlled release systems, comprised of tablets, granules, pills, sachets, powders, capsules, solutions or fluids, all of the above for use in the treatment of physical disorders, emergencies and traumas, burns, diseases of the heart and blood vessels, neurological diseases, and cancer

Medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals

Education and training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical and pharmaceutical fields

Scientific and technological services, namely, scientific research, analysis and testing in the field of medical science, pharmacology, biotechnology and bacteriological areas and providing consultation and information relating thereto; design of drug delivery systems for medical use; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 9, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 26, 2025 ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 5, 2025 ERRR
USE AFFIDAVIT FAILED FORMALITIES
Apr 1, 2025 IUFF
NOTICE OF ALLOWANCE CANCELLED
Apr 1, 2025 IUCN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 15, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 20, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 31, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 12, 2024 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 12, 2024 RCCK
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 9, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 11, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 11, 2023 GNSL
SUSPENSION LETTER WRITTEN
Oct 11, 2023 CNSL
ASSIGNED TO EXAMINER
Oct 11, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2023 NWOS
NEW APPLICATION ENTERED
Jan 17, 2023 NWAP